Patients with congenital bleeding disorders appear to be less severely affected by SARS-CoV-2: is inherited hypocoagulability overcoming acquired hypercoagulability of … A Dorgalaleh, A Dabbagh, S Tabibian, MR Baghaeipour, M Jazebi, ... Seminars in thrombosis and hemostasis 46 (07), 853-855, 2020 | 38 | 2020 |
Molecular basis of rare congenital bleeding disorders A Dorgalaleh, M Bahraini, M Shams, F Parhizkari, A Dabbagh, T Naderi, ... Blood Reviews 59, 101029, 2023 | 19 | 2023 |
Gastrointestinal bleeding in a newborn infant with congenital factor X deficiency and COVID‐19—A common clinical feature between a rare disorder and a new, common infection. A Dorgalaleh, MR Baghaipour, S Tabibian, F Ghazizadeh, A Dabbagh, ... International Journal of Laboratory Hematology 42 (6), 2020 | 9 | 2020 |
Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19 A Fazeli, S Sharifi, F Behdad, S Okati, G Esmaielifar, N Jelveh, P Eshghi, ... Transfusion and Apheresis Science 61 (2), 103321, 2022 | 8 | 2022 |
The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection A Fazeli, S Sharifi, S Mohammadi, M Bahraini, A Arabkhazaeli, N Jelveh, ... Transfusion and Apheresis Science 61 (2), 103302, 2022 | 6 | 2022 |
Challenges and concerns of patients with congenital bleeding disorders affected by coronavirus disease 2019 A Dorgalaleh, S Tabibian, MR Baghaipour, A Dabbagh, G Bahoush, ... Blood Coagulation & Fibrinolysis 32 (3), 200-203, 2021 | 4 | 2021 |
Laboratory diagnosis of activated protein c resistance and factor V Leiden M Bahraini, A Fazeli, A Dorgalaleh Seminars in thrombosis and hemostasis, 2023 | 2 | 2023 |
Therapeutic and Diagnostic Approaches for SARS-CoV-2 F Moshfegh, A Ezzati, A Ezzati, M Bahraini, E Boluki, A Fazeli Voice of the Publisher 7 (2), 63-79, 2021 | 2 | 2021 |
Monitoring Blood Transfusion Policies and Implementation of Maximum Surgical Blood Ordering Schedule F Moshfegh, N Farahbakhsh, M Bahraini, J Kardan-Yamchi, A Fazeli, ... Global Journal of Transfusion Medicine 8 (2), 146-151, 2023 | | 2023 |
Adoptive Chimeric Antigen Receptor T Cell (CAR-T) and Treg Cell-Based Immunotherapies: Frontier Therapeutic Aspects in Cancers M Bahraini, A Fazeli Acta Medica Iranica, 570-577, 2021 | | 2021 |
The Relationships between the Alteration of MAP1LC3B, and BECN1 Gene Expression with Minimal Residual Disease in Acute Lymphoblastic Leukemia Patients M Hayatmanesh, G Tamaddon, A Fazeli, T Kalantari Middle East Journal of Cancer 12 (3), 350-356, 2021 | | 2021 |
Evaluation of FOXP1 gene expression in pediatric B-cell precursor acute lymphoblastic leukemia patients at remission induction therapy G Tamaddon, M Bahraini, A Fazeli Iranian Journal of Pediatric Hematology & Oncology, 2020 | | 2020 |